Bridget E. Bunner

Array ( [id] => 6212351 [patent_doc_number] => 20110135651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'METHOD AND COMPOSITION FOR ENHANCING HEMATOPOIETIC STEM CELL MOBILIZATION' [patent_app_type] => utility [patent_app_number] => 13/057458 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6308 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135651.pdf [firstpage_image] =>[orig_patent_app_number] => 13057458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494066 [patent_doc_number] => 20100009918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'METHOD FOR THE ADMINISTRATION OF LIGANDS, AGONISTS OF LIGANDS OF THE TNF FAMILY WITH REDUCED TOXICITY' [patent_app_type] => utility [patent_app_number] => 12/542183 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5571 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009918.pdf [firstpage_image] =>[orig_patent_app_number] => 12542183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477666 [patent_doc_number] => 20100041608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'METHOD FOR STIMULATING WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 12/538714 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6326 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041608.pdf [firstpage_image] =>[orig_patent_app_number] => 12538714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9523908 [patent_doc_number] => 08748170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Polypeptides derived from cyclin B1 and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/055907 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 2 [patent_no_of_words] => 3945 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398213 [patent_doc_number] => 08268592 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Anti-system ASC amino acid transporter 2 (ASCT2) antibody' [patent_app_type] => utility [patent_app_number] => 12/505133 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 50808 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12505133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958464 [patent_doc_number] => 20110182851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'OXIDIZED LDL SPECIFIC ANTIBODY-FUSION AND CONJUGATED PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/003648 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3551 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182851.pdf [firstpage_image] =>[orig_patent_app_number] => 13003648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662283 [patent_doc_number] => 20110311552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'NOTCH1 RECEPTOR BINDING AGENTS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/003013 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33841 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311552.pdf [firstpage_image] =>[orig_patent_app_number] => 13003013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314244 [patent_doc_number] => 20100111958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Notch-Binding Agents and Antagonists and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/499627 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 54826 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111958.pdf [firstpage_image] =>[orig_patent_app_number] => 12499627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972473 [patent_doc_number] => 20110152173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/001087 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 41179 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152173.pdf [firstpage_image] =>[orig_patent_app_number] => 13001087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12283216 [patent_doc_number] => 09931386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-03 [patent_title] => Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity [patent_app_type] => utility [patent_app_number] => 12/483876 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 101 [patent_no_of_words] => 22566 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12483876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710113 [patent_doc_number] => 20120003181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Novel Retinoid Inducible Factor and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/997034 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9958 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12997034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494254 [patent_doc_number] => 20100009934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'BETA ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF B-CELL PROLIFERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/480034 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24520 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009934.pdf [firstpage_image] =>[orig_patent_app_number] => 12480034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6229863 [patent_doc_number] => 20100184091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Method for determining MIF content' [patent_app_type] => utility [patent_app_number] => 12/477889 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 31349 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184091.pdf [firstpage_image] =>[orig_patent_app_number] => 12477889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6358893 [patent_doc_number] => 20100087358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'NOTCH mutations leading to increased receptor signaling' [patent_app_type] => utility [patent_app_number] => 12/453833 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 11186 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087358.pdf [firstpage_image] =>[orig_patent_app_number] => 12453833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8293986 [patent_doc_number] => 08221765 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Multivalent fibronectin based scaffold domain proteins' [patent_app_type] => utility [patent_app_number] => 12/470989 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 63 [patent_no_of_words] => 40316 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12470989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304118 [patent_doc_number] => 20090298770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'MAMMALIAN RELAXIN RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/426771 [patent_app_country] => US [patent_app_date] => 2009-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15641 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298770.pdf [firstpage_image] =>[orig_patent_app_number] => 12426771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552287 [patent_doc_number] => 20090286273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'USE OF NEUREGULIN-BETA AS AN INDICATOR AND/OR TARGET' [patent_app_type] => utility [patent_app_number] => 12/424962 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7259 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286273.pdf [firstpage_image] =>[orig_patent_app_number] => 12424962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087865 [patent_doc_number] => 20110217294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'COMBINATION OF HGF INHIBITOR AND HEDGEHOG INHIBITOR TO TREAT CANCER' [patent_app_type] => utility [patent_app_number] => 12/935264 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10703 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217294.pdf [firstpage_image] =>[orig_patent_app_number] => 12935264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5945113 [patent_doc_number] => 20110105733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'SINGLE VARIABLE DOMAINS AGAINST THE NOTCH PATHWAYS' [patent_app_type] => utility [patent_app_number] => 12/934766 [patent_app_country] => US [patent_app_date] => 2009-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 90474 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105733.pdf [firstpage_image] =>[orig_patent_app_number] => 12934766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5928896 [patent_doc_number] => 20110038855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'TRAIL AND METHODS OF MODULATING T CELL ACTIVITY AND ADAPTIVE IMMUNE RESPONSES USING TRAIL' [patent_app_type] => utility [patent_app_number] => 12/417487 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 36612 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038855.pdf [firstpage_image] =>[orig_patent_app_number] => 12417487 [rel_patent_id] =>[rel_patent_doc_number] =>)